Chromosome Analysis, Hematologic Malignancy

Understand what Chromosome Analysis, Hematologic Malignancy signals

LOINC codes: 29770-5
Commercial laboratory assays: 1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Chromosome Analysis, Hematologic Malignancy

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Chromosome Analysis, Hematologic Malignancy

Laboratory: Quest Diagnostics
Test code: 14600
Specimen: Blood
Fasting: Not stated
LOINC: 29770-5
Turnaround: Set up: Daily (a.m.); Report available: 10 days

Laboratory assay overview

Cytogenetics of hematologic disorders attempts to define and interpret chromosomal aberrations that occur in neoplastic cells associated with leukemia, lymphoma and other hematologic malignancies. Chromosome abnormalities in cancer cells of patients with malignant hematologic disorders including acute and chronic myeloid and lymphoid leukemias, myelodysplastic and myeloproliferative disorders, lymphomas and unexplained anemias may correlate with the diagnosis, prognosis, treatment and etiology of disease.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 14600

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.